UD

Urmila Devi Consul

Director Director DIN 01127033
DIN 01127033 First appointment Jan 2007 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Jan 2007
Shareholding value β€’β€’β€’β€’ Premium profile

About Urmila Devi Consul

Data last updated:

Urmila Devi Consul was a Director at Consul Medi-Impex Private Limited (2007–2014) and Director at Neelkanth Enclave Private Limited (from 2007). The companies operate in Healthcare.

DIN 01127033
Primary Designation Director
Industry Healthcare
First Appointment 19 Jan 2007
Oldest Company Age 21 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Consul Medi-Impex Private Limited U51507WB2004PTC097916
Director10 Jun 20072004₹6.2 Lakh (FY 2022)Active
Neelkanth Enclave Private Limited U70101WB2005PTC105898
Director19 Jan 20072005Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Neelkanth Enclave Private Limited
Consul Medi-Impex Private Limited
Premium access

Shareholding and investment profile for Urmila Devi Consul

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Urmila Devi Consul

Urmila Devi Consul was first appointed on 19 Jan 2007 as Director at Neelkanth Enclave Private Limited.

Urmila Devi Consul held 2 earlier board appointments: Consul Medi-Impex Private Limited (Director, 10 Jun 2007 to 29 Jul 2014); Neelkanth Enclave Private Limited (Director, from 19 Jan 2007).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available